Terumo Corp. (OTCMKTS:TRUMY - Get Free Report)'s share price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $18.45 and traded as low as $16.50. Terumo shares last traded at $16.73, with a volume of 184,661 shares trading hands.
Terumo Price Performance
The stock has a market cap of $24.78 billion, a price-to-earnings ratio of 32.19 and a beta of 0.79. The stock's 50 day moving average price is $18.45 and its two-hundred day moving average price is $18.61. The company has a quick ratio of 1.78, a current ratio of 3.00 and a debt-to-equity ratio of 0.12.
Terumo (OTCMKTS:TRUMY - Get Free Report) last released its quarterly earnings data on Wednesday, May 14th. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.07). The business had revenue of $1.79 billion during the quarter, compared to analyst estimates of $1.79 billion. Terumo had a return on equity of 8.48% and a net margin of 11.28%.
Terumo Company Profile
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Recommended Stories
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.